Junichi Fukada
Overview
Explore the profile of Junichi Fukada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
192
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shimane G, Kitago M, Endo Y, Aiura K, Yagi H, Abe Y, et al.
World J Surg Oncol
. 2024 Dec;
22(1):336.
PMID: 39707428
Background/objectives: This study aimed to evaluate the safety, efficacy, and long-term outcomes of S-1-based neoadjuvant chemoradiotherapy (NACRT) in patients with resectable or borderline-resectable pancreatic ductal adenocarcinoma (PDAC). Methods: This retrospective...
2.
Hanada T, Fukada J, Shiraishi Y, Yoshida K, Sakanoue N, Oguma K, et al.
BJR Case Rep
. 2024 Jul;
10(4):uaae021.
PMID: 39027402
Volumetric-modulated arc therapy (VMAT) with field-extended multi-isocentre irradiation (VMAT-FEMII) is an effective irradiation technique, particularly for large planning target volumes in the craniocaudal direction. A variety of treatment planning techniques...
3.
Yoshida K, Hanada T, Fukada J, Kawamura M, Shigematsu N
Keio J Med
. 2024 Feb;
73(2):15-23.
PMID: 38403636
Radiation-induced nausea and vomiting (RINV) is a frequent adverse event that occurs in patients undergoing radiotherapy. However, research on RINV is underrepresented. This prospective single-institution exploratory pilot study investigated the...
4.
Hongo H, Kosaka T, Suzuki Y, Mikami S, Fukada J, Oya M
Sci Rep
. 2021 Nov;
11(1):22284.
PMID: 34782700
Cabazitaxel (CBZ) is approved for the treatment of docetaxel-resistant castration-resistant prostate cancer (CRPC). However, its efficacy against CRPC is limited, and there are no effective treatments for CBZ-resistant CRPC. This...
5.
Fukada J, Fukata K, Koike N, Kota R, Shigematsu N
Sci Rep
. 2021 Sep;
11(1):18166.
PMID: 34518576
We investigated the normal tissue complication probability (NTCP) of the incidence of pericardial effusion (PCE) based on the mean heart dose (MHD) in patients with oesophageal cancer treated with definitive...
6.
Koike N, Kota R, Naito Y, Hayakawa N, Matsuura T, Hishiki T, et al.
Commun Biol
. 2020 Aug;
3(1):450.
PMID: 32807853
Under hypoxic conditions, nitroimidazoles can replace oxygen as electron acceptors, thereby enhancing the effects of radiation on malignant cells. These compounds also accumulate in hypoxic cells, where they can act...
7.
Endo Y, Kitago M, Aiura K, Shinoda M, Yagi H, Abe Y, et al.
World J Surg Oncol
. 2019 Aug;
17(1):145.
PMID: 31420046
Background: We aimed to evaluate the efficacy and safety of 5-fluorouracil-based neoadjuvant chemoradiotherapy (NACRT) in patients with resectable/borderline resectable pancreatic ductal adenocarcinoma (PDAC). Methods: This retrospective study investigated the clinicopathological...
8.
Yura M, Takahashi T, Fukuda K, Nakamura R, Wada N, Fukada J, et al.
Case Rep Gastroenterol
. 2018 Oct;
12(3):578-585.
PMID: 30323733
We report a patient with highly advanced gastric carcinoma who was treated successfully with chemoradiotherapy (CRT) comprising S-1 and cisplatin. The patient was a 71-year-old male who was diagnosed with...
9.
Nakahara T, Owaki Y, Kosaka T, Fukada J, Ichimura A, Jinzaki M
Clin Nucl Med
. 2018 May;
43(7):546-547.
PMID: 29742607
A 64-year-old man with castration-resistant prostate cancer received Ra injection to treat bone metastases. The patient underwent a Ra SPECT scan after the first Ra injection in which there was...
10.
Saito S, Ozawa H, Ikari Y, Nakahara N, Ito F, Sekimizu M, et al.
Onco Targets Ther
. 2018 Feb;
11:483-488.
PMID: 29416348
This paper presents an extremely rare case of synovial sarcoma arising from the maxillary sinus, which resulted in a clinically complete response to chemotherapy. Synovial sarcoma is a rare soft...